The FDA will decide on subcutaneous maintenance dosing of lecanemab by August. Some patients are opting for donanemab because that treatment has a set end date. Reaction from clinicians was varied, ...

Children who inherit genetic mutations from parents with early-onset Alzheimer’s typically show signs of dementia at the same ...

Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay, this time in the US. The company has received a complete response letter (CRL) from the FDA for a ...

Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to ...

Last month, the FDA granted approval to Eli Lilly’s donanemab - or Kisunla - for ... risks of amyloid-related imaging abnormalities and cerebral haemorrhage. Perhaps most emblematic of this ...

Additionally, environmental cues such as inflammation and endocrine signaling induce acute thymus atrophy, contributing to the demise of most developing T cells during thymic selection. We discuss the ...

Jan. 23, 2025 — Scientists have shown that specialized cells involved in how the body responds to insulin are activated in the brain after exercise, suggesting that physical activity may ...

The management of atrophic vaginitis may include self-help measures, estrogen replacement, and botanical therapies, as well as education. Self-help measures include the use of water-based vaginal ...

med.m.chiba-u.ac.jp OBJECTIVES Urinary dysfunction and orthostatic hypotension are the prominent autonomic features in multiple system atrophy (MSA). A detailed questionnaire was given and autonomic ...

View the live stream, or join us through our Webex meeting link, starting at 7:50 a.m. Wednesday Oregon Health & Science University is dedicated to improving the health and quality of life for all ...

having to make a speech or being attacked. Here’s why our sleeping brain comes back to these unpleasant dreams again and again ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials ... can include amyloid-related imaging abnormalities (ARIA), which are areas of brain swelling or bleeds Don ...